Refine the list (min. 2 characters)
Keynote Presentation (In-Person)
Cell-based therapy holds great potential to address unmet medical needs and revolutionize the healthcare bioindustry, as demonstrated by CAR-T cell therapy and stem cell transplantation, and has been considered as a promising option in the treatment of ischemic heart disease. The [....] » Read More
Keynote Presentation (In-Person)
Title: Postural orthostatic tachycardia syndrome (POTS)
Background: Postural Orthostatic Tachycardia Syndrome (POTS) is a complex and heterogeneous autonomic nervous system disorder characterised by orthostatic intolerance. Key diagnostic criteria include a sustained increase in heart rate of ≥30 bpm (or ≥40 bpm in children/adol [....] » Read More
Keynote Presentation (In-Person)
Title: Post-translational modifications of proteins in cardiovascular diseases
Protein post-translational modifications, particularly reversible lysine acylation, have emerged as critical arbiters of cardiac homeostasis and disease. Our group has systematically employed quantitative PTM proteomics to elucidate the roles of propionylation, crotonylation, and [....] » Read More
Oral Presentation (In-Person)
Title: Chronic kidney Disease: Looking Beyond Diabetes
A “perilous Paradox” of our time…Some of the greatest human and economic burden is caused by one of the most treatable yet underdiagnosed conditions: chronic kidney disease. Our current practice is to diagnose too late, begin treatment too late, too conservativ [....] » Read More
Keynote Presentation (Virtual)
Title: Vulnerable plaque stabilization with OMT vs preventive PCI
Background: This study demonstrates the recent strategy utilized in the management of vulnerable coronary plaques, with a major focus on the fact that instead of severe narrowed coronary arteries, plaque rupture is the major reason behind various STEMI events and sudden cardiac d [....] » Read More
Keynote Presentation (Virtual)
Background: The rapid expansion of digital health data and advances in artificial intelligence (AI) and machine learning (ML) have created new opportunities for laboratory medicine. Cardiovascular diseases (CVDs), a leading cause of global mortality, particularly in populati [....] » Read More
Oral Presentation (Virtual)
Title: Behavioural signals before clinical thresholds: How AI Is rewriting early cardiovascular risk
Cardiovascular disease remains the leading cause of death worldwide, yet most patients are still identified only after they have crossed a clinical threshold: a hypertensive reading, an abnormal lipid panel, a stress test that finally turns positive. By the time these markers cro [....] » Read More
Oral Presentation (Virtual)
Title: Mechanical circulatory support and transplantation in adult congenital heart disease
As the adult population with congenital heart disease (ACHD) continues to grow due to the improved survival in pediatric cardiac surgery, heart failure in this group of patients has become an increasing problem in the last two decades. If the conservative treatment fails, m [....] » Read More
Oral Presentation (Virtual)
Background: Cannabis use is increasingly encountered in emergency care, yet its cardiovascular effects are often underrecognized when younger patients present with chest pain, palpitations, syncope, or neurologic symptoms. This review synthesized current evidence and developed a [....] » Read More
Poster Presentation (Virtual)
Background: Chronic heart failure (CHF) is a major contributor to global morbidity and mortality, and its progression is frequently complicated by cardiorenal syndrome—a bidirectional pathological interaction between the heart and kidneys. Endothelial dysfunction plays a ce [....] » Read More
Copyright 2024 Mathews International LLC All Rights Reserved
